Drug Information Analysis Service

Richardson DW Robinson AG . Desmopressin. Ann Intern Med 1985; 103: 228–39.

Salzman EW Weinstein MJ Weintraub RM . Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med 1986; 314: 1402–6.

Sawyer WH Acosta M Balaspiri L . Structural changes in the arginine vasopressin molecule that enhance antidiuretic activity and specificity. Endocrinology 1974; 94: 1106–15.

Mannucci PM Ruggeri ZM Paretti FI Capitanio A . 1-deamino-8-D-arginine vasopressin: A new pharmacological approach to the management of hemophilia and von Willebrand's disease. Lancet 1977; 1: 869–72.

Harker LA . Bleeding after cardiopulmonary bypass. N Engl J Med 1986: 314: 1446–8.

Harker LA Malpass TW Bramson HE . Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective-granule release. Blood 1980; 56: 824–34.

Mammen EF Koets MH Washington BC . Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 1985; 11: 281–92.

Mannucci PM Canciani MT Rota L Donovan BS . Response of factor VIII/von Willebrand factor to dDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease. Br J Haematol 1981; 47: 283–93.

Czer L Bateman TM Gray R . Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: Reduction in blood product usage with desmopressin. J Am Coll Cardiol 1987; 915: 1139–47.

Mannucci PM Remuzzi G Pusineri F . Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983; 308: 8–12.

Kobrinsky NL Israels ED Gerrard JM . Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet 1984; 1: 1145–8.

Mannucci PM Vicente V Vianello L . Controlled trial of desmopressin (dDAVP) in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 1986; 67: 1148–53.

Kobrinsky NL Letts RM Patel LR . 1-desamino-8-D-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. Ann Intern Med 1987; 107: 446–50.

Stone DJ Difagio CA . DDAVP to reduce blood loss in Jehovah's Witness. Anesthesiology 1988; 69: 119–22.

Brommer EJP Van Brummelen P Derkx FHM . Desmopressin and hypotension (letter). Ann Intern Med 1985; 103: 962.

D'Alauro FS Johns RA . Hypotension related to desmopressin administration following cardiopulmonary bypass. Anesthesiology 1988; 69: 962–3.

Glueck CJ . Classification and diagnosis of hyperlipoproteinemia. In: Rifkind BM Levy RI , eds. Hyperlipidemia—diagnosis and therapy. New York: Grune & Stratton, 1979: 17–39.

Rodondi KM . Hyperlipidemia. In: Herfindal ET Gourley DR Hart LL , eds. Clinical pharmacy and therapeutics, 4th ed. Baltimore: Williams & Wilkins, 1988: 199–206.

Reynold JEF , ed. Martindale, the extra pharmacopoeia. 28th ed. London: Pharmaceutical Press, 1982: 954.

Jenkins DJA . The cholesterol lowering properties of guar and pectin (abstract). Clin Sci Molec Med 1976; 51: 8P–9P.

Blackburn NA Redfern JS Jarjis H . The mechanism of action of guar gum in improving glucose tolerance in man. Clin Sci 1984; 66: 329–36.

Wahren J Juhlin-Dannfelt A Bjorkman O Defronzo R Felig P . Influence of fibre ingestion on carbohydrate utilization and absorption. Clin Physiol 1982; 2: 315–21.

Baththena SJ Avigan J Schreiner JE . Effect of insulin on sterol and fatty acid synthesis and hydroxymethylgutaryl-CoA reductase activity in mammalian cells grown in culture. Proc Natl Acad Sci USA 1974; 71: 2174–8.

Reaven GM Bernstein RM . Effect of obesity on the relationship between very low lipid density lipoprotein production rate and plasma triglyceride concentration in normal and hypertriglyceridemic subjects. Metabolism 1978; 27: 1047–54.

Bosello O Cominacini L Zocca I Garbin U Ferrari F Davoli A . Effects of guar gum in plasma lipoproteins and apolipoproteins CII and CIII in patients affected by familial combined hyperlipoproteinemia. Am J Clin Nutr 1984; 40: 1165–74.

Jenkins DJA Reynold D Slavin B Leeds AR Jenkins AL Jepson EM . Dietary fiber and blood lipids: Treatment of hypercholesterolemia with guar crispbread. Am J Clin Nutr 1980; 33: 575–81.

Aro A Uusitupa M Voutilainen E Korhonen T . Effects of guar gum in male subjects with hypercholesterolemia. Am J Clin Nutr 1984; 39: 911–6.

Tuomilehto J Karttunen P Vinni S Kostiainen E Uusitupa M . A double-blind evaluation of guar gum in patients with dyslipidemia. Hum Nutr Clin Nutr 1983; 37: 109–16.

Superko HR Haskell WL Sawrey-Kubicek L Farquhar JW . Effects of solid and liquid guar on plasma cholesterol and triglyceride concentrations in moderate hypercholesterolemia. Am J Cardiol 1988; 62: 51–5.

Simons LA Gayst S Balasubramaniam S Ruys J . Long-term treatment of hypercholesterolemia with a new palatable formulation of guar gum. Atherosclerosis 1982; 45: 101–8.

Gatti E Catenazzo G Camisasca E Torri A Denegri E Sirtori CR . Effect of guar enriched pasta in the treatment of diabetes and hyperlipidemia. Ann Nutr Metab 1984; 28: 1–10.

Sheskin J . Thalidomide in the treatment of the lepra reaction. Clin Pharmacol Ther 1965; 6: 303–6.

Koch HP . Thalidomide and its congeners as antiinflammatory agents. Prog Med Chem 1985; 22: 165–242.

Sheskin J Convit J . Results of a double-blind study of the influence of thalidomide on the lepra reaction. Int J Lepr 1969; 37: 135–46.

Iyer CGS Languillon J Ramanujam K . WHO coordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients. Bull WHO 1971; 45: 719–32.

Pearson JMH Vedagiri M . Treatment of moderately severe erythema nodosum leprosum with thalidomide—a double-blind controlled trial. Lepr Rev 1969; 40: 111–6.

Waters MFR . An internally-controlled double-blind trial of thalidomide in severe erythema nodosum leprosum. Lepr Rev 1971; 42: 26–42.

Ramu G Girdhar A . Treatment of steroid dependent cases of recurrent lepra reaction with a combination of thalidomide and clofazimine. Lepr India 1979; 51: 497–504.